Aprea Therapeutics Inc (APRE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -37,127 | -29,372 | -19,920 | -9,669 | -53,479 |
| Depreciation Amortization | 272 | 206 | 136 | 76 | 230 |
| Accounts payable and accrued liabilities | -2,731 | -1,955 | -2,142 | -1,047 | 2,327 |
| Other Working Capital | -8,327 | -3,816 | -2,907 | -3,230 | 5,573 |
| Other Operating Activity | 10,227 | 7,431 | 5,559 | 2,348 | 3,546 |
| Operating Cash Flow | $-37,686 | $-27,507 | $-19,274 | $-11,522 | $-41,803 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | N/A | N/A | N/A | -26 |
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $-26 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 1,747 | 87 | N/A | N/A | 151 |
| Financing Cash Flow | $1,747 | $87 | $N/A | $N/A | $151 |
| Exchange Rate Effect | -3 | -169 | 60 | 121 | 606 |
| Beginning Cash Position | 89,018 | 89,018 | 89,018 | 89,018 | 130,089 |
| End Cash Position | 53,076 | 61,428 | 69,804 | 77,616 | 89,018 |
| Net Cash Flow | $-35,942 | $-27,589 | $-19,214 | $-11,402 | $-41,071 |
| Free Cash Flow | |||||
| Operating Cash Flow | -37,686 | -27,507 | -19,274 | -11,522 | -41,803 |
| Capital Expenditure | N/A | N/A | N/A | N/A | -26 |
| Free Cash Flow | -37,686 | -27,507 | -19,274 | -11,522 | -41,828 |